Dr. Greg Gerdeman is a neuroscientist, cannabinoid researcher and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS). His Ph.D. dissertation in Pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as so-called “retrograde messengers” that regulate synaptic plasticity in the brain.
These findings have become a foundation to modern understanding of the ECS and the neuroprotective actions of
cannabis. Greg’s studies of cannabinoid physiology have been widely cited in the scientific literature, and highlighted in such diverse publications as Science, National Geographic, Men’s Health, and The New York Times. Lecturing often to physicians on cannabis as medicine, Greg is particularly interested in the adaptive roles of endocannabinoids to motivate and support physical exercise, such as by reducing chronic pain and inflammation; and the ways that this inherent biology of humans is supported by our mutualistic relationship with cannabis. His scholarly research has spanned across a wide range of topics, all involving the physiology and evolution of cannabinoid receptors, and has helped to pioneer views of the ECS as a cellular mechanism of homeostasis.
In 2017 Greg resigned a tenured faculty position as professor of biology at Eckerd College (St Petersburg, FL) to become Chief Scientific Officer for 3 Boys Farm: a rainwater harvesting, solar powered, low carbon footprint, USDA certified organic produce farm that is licensed as a vertically integrated cannabis company in the state of Florida.